CLINICAL_TRIALS
trial_result
· 2022-12-07
Clinical Trial Update: Imaging Tumor-infiltrating T-cells in Non-small Cell Lung Cancer [Phase 2]
Summary
Phase 2 trial investigating imaging of tumor-infiltrating T-cells in non-small cell lung cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Radboud University Medical Center | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED